Sotera Health Company (SHC) Guidance & Earnings Results
On 2026-08-06 Sotera Health Company raised guidance: "Revenue growth 5.25-6.75%; Adj. EBITDA growth 5.75-7.25% constant…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SHCSotera Health CompanyFollow SHC — free
—
Price chart with a free account
- Market cap
- 5.2B
- P/E TTM
- 31.8
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 6 Aug 26 | Raised | Revenue growth 5.25-6.75%; Adj. EBITDA growth 5.75-7.25% constant currency · full year |
| 24 Feb 26 | Raised | FY26 revenue growth 5.0-6.5%; Adj EBITDA growth 5.5-7.0% constant currency |
| 12 Jan 26 | Raised | Revenue >$1.16B, +5.5% YoY · full year |
| 4 Nov 25 | Raised | Adjusted EBITDA growth raised to 6.75%-7.75% · full year |
| 8 Aug 25 | Raised | FY2025 net revenues growth raised to 4.5%-6.0% from 4.0%-6.0%; Adjusted EBITDA growth raised to 6.0%-7.5% from 4.5%-6.5%; Interest Expense $155M-$165M; Tax rate 31.5%-33.5% from 33%. · full year |
Sotera Health Company — questions
- What guidance did Sotera Health Company give?
- On 2026-08-06: "Revenue growth 5.25-6.75%; Adj. EBITDA growth 5.75-7.25% constant currency"
- When does Sotera Health Company report earnings?
- Sotera Health Company's next earnings report is expected on 2026-11-03.
Every figure on this page comes from Sotera Health Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.